Diversified Healthcare Trust (NASDAQ:DHC) Stock Now Rated “Moderate Buy” by Sell-Side Analysts

Shares of Diversified Healthcare Trust (NASDAQ:DHC) have received a consensus recommendation of “Moderate Buy” from the six analysts that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation, two have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $9.83.

DHC has been the topic of a number of research analyst reports. Wall Street Zen upgraded Diversified Healthcare Trust from a “sell” rating to a “hold” rating in a research note on Saturday, August 8th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Diversified Healthcare Trust in a report on Thursday, October 15th.

Diversified Healthcare Trust Stock Performance

NASDAQ DHC opened at $7.78 on Friday. The company has a current ratio of 4.66, a quick ratio of 4.67 and a debt-to-equity ratio of 1.52. The firm’s fifty day moving average price is $7.77 and its two-hundred day moving average price is $7.75. Diversified Healthcare Trust has a 1 year low of $3.92 and a 1 year high of $9.66. The firm has a market capitalization of $1.88 billion, a P/E ratio of 18.53 and a beta of 2.29.

Diversified Healthcare Trust (NASDAQ:DHC) last issued its earnings results on Monday, August 3rd. The real estate investment trust reported ($0.16) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.15) by ($0.01). Diversified Healthcare Trust had a negative net margin of 17.73% and a negative return on equity of 16.22%. The firm had revenue of $365.39 million during the quarter, compared to analyst estimates of $370.75 million. As a group, research analysts anticipate that Diversified Healthcare Trust will post 0.60 EPS for the current year.

Diversified Healthcare Trust Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 12th. Stockholders of record on Monday, October 19th will be issued a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date is Monday, October 19th. Diversified Healthcare Trust’s payout ratio is currently -3.60%.

Institutional Trading of Diversified Healthcare Trust

Several hedge funds have recently added to or reduced their stakes in the company. Carronade Capital Management LP grew its stake in Diversified Healthcare Trust by 10.6% during the first quarter. Carronade Capital Management LP now owns 5,268,435 shares of the real estate investment trust’s stock worth $34,982,000 after purchasing an additional 504,898 shares during the period. Bank of New York Mellon Corp acquired a new stake in shares of Diversified Healthcare Trust during the 2nd quarter worth approximately $22,101,000. Bank of America Corp DE grew its position in shares of Diversified Healthcare Trust by 90.4% during the 1st quarter. Bank of America Corp DE now owns 2,682,265 shares of the real estate investment trust’s stock worth $17,810,000 after buying an additional 1,273,681 shares during the period. Allianz Asset Management GmbH increased its stake in shares of Diversified Healthcare Trust by 231.8% in the 2nd quarter. Allianz Asset Management GmbH now owns 1,767,596 shares of the real estate investment trust’s stock valued at $16,439,000 after acquiring an additional 1,234,822 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its stake in shares of Diversified Healthcare Trust by 6.1% in the 1st quarter. Dimensional Fund Advisors LP now owns 2,399,804 shares of the real estate investment trust’s stock valued at $15,935,000 after acquiring an additional 138,708 shares in the last quarter. 75.98% of the stock is owned by institutional investors and hedge funds.

Diversified Healthcare Trust Company Profile

Diversified Healthcare Trust (NASDAQ: DHC) is a real estate investment trust that owns and manages healthcare-related properties in the United States. Its portfolio includes medical office buildings, life science and research facilities, senior living communities, and wellness-oriented properties.

The trust leases its properties to healthcare providers, research organizations, senior living operators, and other related businesses. Its medical office and life science properties support outpatient care, medical research, and healthcare innovation, while its senior living portfolio serves older adults through independent living, assisted living, and related care services.

DHC was formerly known as Senior Housing Properties Trust and adopted its current name in 2020 to reflect its broader healthcare real estate strategy.